Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

mabxience research sl - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - Αντινεοπλασματικοί παράγοντες - alymsys in combination with fluoropyrimidine based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum. alymsys in combination with paclitaxel is indicated for first line treatment of adult patients with metastatic breast cancer. alymsys in combination with capecitabine is indicated for first line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. patients who have received taxane and anthracycline containing regimens in the adjuvant setting within the last 12 months should be excluded from treatment with alymsys in combination with capecitabine. alymsys, in addition to platinum based chemotherapy, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non small cell lung cancer other than predominantly squamous cell histology. alymsys, in combination with erlotinib, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non squamous non small cell lung cancer with epidermal growth factor receptor (egfr) activating mutations. alymsys in combination with interferon alfa 2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer. alymsys, in combination with carboplatin and paclitaxel is indicated for the front line treatment of adult patients with advanced (international federation of gynecology and obstetrics (figo) stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer. alymsys, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. alymsys, in combination with topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. alymsys, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix.

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

janssen-cilag international n.v. - telaprevir - Ηπατίτιδα c, Χρόνια - Αντιιικά για συστηματική χρήση - incivo σε συνδυασμό με πεγκυλιωμένη ιντερφερόνη άλφα και ριμπαβιρίνη, ενδείκνυται για τη θεραπεία από τον γονότυπο 1 της χρόνιας ηπατίτιδας c σε ενήλικες ασθενείς με αντιρροπούμενη ηπατική νόσο (συμπεριλαμβανομένης της κίρρωσης):ποια είναι η θεραπεία αφελείς, που έχουν προηγουμένως υποβληθεί σε θεραπεία με ιντερφερόνη άλφα (πεγκυλιωμένη ή μη πεγκυλιωμένη) μόνη της ή σε συνδυασμό με ριμπαβιρίνη, συμπεριλαμβανομένων relapsers, μερική ανταπόκριση και μηδενική ανταπόκριση.

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

medochemie ltd (0000003169) 1-10 constantinoupoleos str, lemesos, 3011, 51409 (3505) - lincomycin hydrochloride monohydrate - solution for injection or infusion - 300mg/ml - lincomycin hydrochloride monohydrate (0007179499) 340,2mg - lincomycin

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

baxter holding b.v. (0000011218) kobaltweg 49, utrecht, 3542 ce - magnesium chloride hexahydrate; sodium chloride; sodium bicarbonate; potassium chloride; disodium phosphate dihydrate - solution for haemofiltration and haemodialysis - 22mmol/l - magnesium chloride hexahydrate (0007791186) 3,05g; sodium chloride (0007647145) 7,01g; sodium bicarbonate (0000144558) 2,12g; potassium chloride (0007447407) 0,314g; disodium phosphate dihydrate (8000002150) 0,187g - hemofiltrates

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

baxter holding b.v. (0000011218) kobaltweg 49, utrecht, 3542 ce - sodium bicarbonate; sodium chloride; magnesium chloride hexahydrate; calcium chloride dihydrate; lactic acid; potassium chloride; glucose monohydrate - solution for haemofiltration and haemodialysis - 4mmol/l - sodium bicarbonate (0000144558) 3,09g; sodium chloride (0007647145) 6,45g; magnesium chloride hexahydrate (0007791186) 2,033g; calcium chloride dihydrate (0010035048) 5,145g; lactic acid (0000050215) 5,4g; potassium chloride (0007447407) 0,314g; glucose monohydrate (0005996101) 24,2g - hemofiltrates

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

baxter holding b.v. (0000011218) kobaltweg 49, utrecht, 3542 ce - calcium chloride dihydrate; potassium chloride; sodium chloride; magnesium chloride hexahydrate; sodium bicarbonate; glucose monohydrate; lactic acid - solution for haemofiltration and haemodialysis - 2mmol/l - calcium chloride dihydrate (0010035048) 5,145g; potassium chloride (0007447407) 0,157g; sodium chloride (0007647145) 6,45g; magnesium chloride hexahydrate (0007791186) 2,033g; sodium bicarbonate (0000144558) 3,09g; glucose monohydrate (0005996101) 24,2g; lactic acid (0000050215) 5,4g - hemofiltrates

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

baxter holding b.v. (0000011218) kobaltweg 49, utrecht, 3542 ce - sodium bicarbonate; sodium chloride; s-lactic acid; magnesium chloride hexahydrate; calcium chloride dihydrate - solution for haemofiltration and haemodialysis - sodium bicarbonate (0000144558) 3,09g; sodium chloride (0007647145) 6,45g; s-lactic acid (8000004602) 5,4g; magnesium chloride hexahydrate (0007791186) 2,033g; calcium chloride dihydrate (0010035048) 5,145g

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

baxter (hellas) epe (0000008332) 47, marinou antypa & anafis str, n. herakleio-attiki, 141 21 - glucose monohydrate; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium chloride; sodium bicarbonate; sodium (s)-lactate solution; glucose monohydrate; sodium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium bicarbonate; sodium (s)-lactate solution - solution for peritoneal dialysis - 1.36% w/v - glucose monohydrate (0005996101) 20g; calcium chloride dihydrate (0010035048) 0,343g; magnesium chloride hexahydrate (0007791186) 0,068g; sodium chloride (0007647145) 21,12g; sodium bicarbonate (0000144558) 9,29g; sodium (s)-lactate solution (8000002516) 4,48g; glucose monohydrate (0005996101) 15g; sodium chloride (0007647145) 5,67g; calcium chloride dihydrate (0010035048) 0,257g; magnesium chloride hexahydrate (0007791186) 0,051g; sodium bicarbonate (0000144558) 2,1g; sodium (s)-lactate solution (8000002516) 1,12g - hypertonic solutions

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

baxter (hellas) epe (0000008332) 47, marinou antypa & anafis str, n. herakleio-attiki, 141 21 - glucose monohydrate; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium chloride; sodium bicarbonate; sodium (s)-lactate solution; glucose monohydrate; sodium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium bicarbonate; sodium (s)-lactate solution - solution for peritoneal dialysis - 2.27% w/v - glucose monohydrate (0005996101) 33,3g; calcium chloride dihydrate (0010035048) 0,343g; magnesium chloride hexahydrate (0007791186) 0,068g; sodium chloride (0007647145) 21,12g; sodium bicarbonate (0000144558) 9,29g; sodium (s)-lactate solution (8000002516) 4,48g; glucose monohydrate (0005996101) 25g; sodium chloride (0007647145) 5,67g; calcium chloride dihydrate (0010035048) 0,257g; magnesium chloride hexahydrate (0007791186) 0,051g; sodium bicarbonate (0000144558) 2,1g; sodium (s)-lactate solution (8000002516) 1,12g - hypertonic solutions

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

baxter (hellas) epe (0000008332) 47, marinou antypa & anafis str, n. herakleio-attiki, 141 21 - glucose monohydrate; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium chloride; sodium bicarbonate; sodium (s)-lactate solution; glucose monohydrate; sodium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium bicarbonate; sodium (s)-lactate solution - solution for peritoneal dialysis - 3.86% w/v - glucose monohydrate (0005996101) 56,6g; calcium chloride dihydrate (0010035048) 0,343g; magnesium chloride hexahydrate (0007791186) 0,068g; sodium chloride (0007647145) 21,12g; sodium bicarbonate (0000144558) 9,29g; sodium (s)-lactate solution (8000002516) 4,48g; glucose monohydrate (0005996101) 42,5g; sodium chloride (0007647145) 5,67g; calcium chloride dihydrate (0010035048) 0,257g; magnesium chloride hexahydrate (0007791186) 0,051g; sodium bicarbonate (0000144558) 2,1g; sodium (s)-lactate solution (8000002516) 1,12g - hypertonic solutions